Fetal Alcohol Syndrome: Socio-Cognitive Habilitation
Launched by CENTERS FOR DISEASE CONTROL AND PREVENTION · Sep 9, 2005
Trial Information
Current as of May 12, 2025
Completed
Keywords
ClinConnect Summary
Learning Readiness Program: This program will include: case management to secure needed services, medication consultation (psychiatrist), educational consultation/ liaison, Behavioral Regulation Training (BRT). BRT will include teaching parents about: 1) recognizing their child's arousal level (to avoid negative episodes), 2) recognizing their own arousal and how it contributes to a situation, 3) principles of social reinforcement (e.g., praise, ignore, etc), 4) "accidental teaching" (i.e., teaching when a situation/opportunity arises), 5) resource/support source identification, 6) to commu...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • diagnosis of FAS or related condition
- • age 3 years six month or older
- Exclusion Criteria:
- • age 6 years 9 months or older
About Centers For Disease Control And Prevention
The Centers for Disease Control and Prevention (CDC) is a leading national public health institute in the United States, dedicated to protecting public health and safety through the prevention and control of diseases, injuries, and disabilities. As a clinical trial sponsor, the CDC focuses on innovative research to inform and enhance public health practices, develop effective interventions, and evaluate health outcomes. By facilitating rigorous scientific studies, the CDC aims to generate evidence-based solutions that address pressing health challenges, promote health equity, and improve the overall well-being of communities nationwide. Through collaboration with various stakeholders, including academic institutions and healthcare organizations, the CDC plays a crucial role in advancing knowledge and policies that safeguard public health.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Atlanta, Georgia, United States
Patients applied
Trial Officials
claire coles, PhD
Principal Investigator
Marcus Institute
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials